NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,470,328 | -74.9% | 81,944 | -63.2% | 0.00% | -71.4% |
| Q1 2023 | $13,827,319 | -29.8% | 222,698 | +9.3% | 0.01% | -36.4% |
| Q4 2022 | $19,704,463 | +25.7% | 203,769 | +10.4% | 0.01% | +22.2% |
| Q3 2022 | $15,681,000 | +33.8% | 184,585 | +14.7% | 0.01% | 0.0% |
| Q2 2022 | $11,724,000 | +67.4% | 160,967 | +97.7% | 0.01% | +80.0% |
| Q1 2022 | $7,003,000 | +39.8% | 81,400 | +13.3% | 0.01% | +66.7% |
| Q4 2021 | $5,011,000 | -37.5% | 71,872 | +4.1% | 0.00% | -50.0% |
| Q3 2021 | $8,019,000 | -36.7% | 69,030 | +20.9% | 0.01% | -33.3% |
| Q2 2021 | $12,665,000 | – | 57,090 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |